Translating translation into patient benefit for atopic eczema.
This review considers, in the context of British Skin Foundation (BSF)-funded translational research into atopic eczema conducted in Newcastle, the complex interactions between clinical and non-clinical scientists in both academia and industry and how this may have impacted on clinical care. However, research in individual centres does not occur in isolation and clinically relevant outcomes from collaborative research are increasingly supported through regional and national networks. This is illustrated by our trial of azathioprine in adults with atopic eczema conducted across centres in the North East of England that employed pharmacogenetic dosimetry. Correspondingly the formation of a UK Translational Network for Translational Research in Dermatology (UK TREND) has facilitated the development of a UK-wide network to support atopic eczema projects based on an e-Delphi prioritisation exercise.
Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, NE2 4HH, U.K. nick.reynolds@ncl.ac.uk.|Department of Dermatology, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, U.K. nick.reynolds@ncl.ac.uk.
N J
NJ
Reynolds
Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, NE2 4HH, U.K.|Department of Dermatology, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, U.K.
A
A
Sinha
Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, NE2 4HH, U.K.
M S
MS
Elias
Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, NE2 4HH, U.K.|Department of Dermatology, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, U.K.
S J
SJ
Meggitt
Arch Dermatol. 2009 Jun;145(6):644-52
19528417
Int J Rheum Dis. 2014 Feb;17(2):132-41
24618304
Br J Dermatol. 2011 Oct;165(4):711-34
21950502
J Am Acad Dermatol. 2013 Jan;68(1):29-35
22892285
Arch Dermatol. 2006 Sep;142(9):1190-6
16983006
Arch Dermatol. 2011 Apr;147(4):474-88
21482898
Br J Dermatol. 2002 Aug;147(2):324-30
12174106
Kidney Int. 1998 Aug;54(2):536-45
9690221
Am J Hum Genet. 2015 Jan 8;96(1):104-20
25574825
Br J Dermatol. 1990 May;122(5):665-9
2112945
J Invest Dermatol. 2007 Mar;127(3):564-7
16990802
Stat Med. 1993 Jan 15;12(1):27-37
8446801
J Allergy Clin Immunol. 2014 Feb;133(2):429-38
24269258
BMJ. 1990 Jan 27;300(6719):230-5
2106931
Gastroenterology. 2006 Apr;130(4):1047-53
16618398
Pharmacogenomics. 2014 Apr;15(6):745-57
24897283
Science. 2005 Sep 16;309(5742):1871-4
16166520
J Clin Pharm Ther. 2007 Apr;32(2):187-95
17381669
Br J Dermatol. 2013 Oct;169(4):901-9
23855450
Lancet. 2001 Jun 23;357(9273):2012-6
11438134
J Invest Dermatol. 2011 May;131(5):1085-94
21270823
Br J Dermatol. 1998 Mar;138(3):443-9
9580797
Health Technol Assess. 2000;4(37):1-191
11134919
J Eur Acad Dermatol Venereol. 2012 Sep;26(9):1176-93
22813359
Br J Dermatol. 2017 Jun;176(6):1617-1623
27943248
Lancet. 2006 Mar 11;367(9513):839-46
16530578
Br J Dermatol. 2015 Nov;173(5):1191-1198
26149834
Clin Exp Dermatol. 2001 Jul;26(5):369-75
11488818
Scand J Rheumatol. 1999;28(2):65-8
10229133